Genomma Lab Internacional, S.A.B. de C.V. Stock
Stocks
LAB B
MX01LA010006
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.33 MXN | +0.66% |
|
+2.47% | -14.31% |
| Market Cap | 14.95B 855M 748M 687M 641M 1.22B 81.45B 1.23B 8.25B 3.21B 40.04B 3.21B 3.14B 138B | P/E 2026 * |
6.98x | P/E 2027 * | 6.91x |
|---|---|---|---|---|---|
| Enterprise Value | 18.81B 1.08B 941M 865M 806M 1.53B 102B 1.55B 10.38B 4.04B 50.38B 4.04B 3.95B 174B | EV / Sales 2026 * |
1.03x | EV / Sales 2027 * | 0.96x |
| Free-Float |
68.95% | Yield 2026 * |
5.23% | Yield 2027 * | 7.16% |
Last Transcript: Genomma Lab Internacional, S.A.B. de C.V.
| 1 day | +0.66% | ||
| 1 week | +2.47% | ||
| Current month | +2.00% | ||
| 3 months | -18.37% | ||
| 6 months | -14.50% | ||
| Current year | -14.31% |
| 1 week | 14.65 |  | 15.7 |
| 1 month | 14.24 | | 15.7 |
| Current year | 14.24 | | 19.48 |
| 1 year | 14.24 | | 23.6 |
| 3 years | 12.39 | | 29.18 |
| 5 years | 12.39 | | 29.18 |
| 10 years | 11.1 | | 29.18 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marco Sparvieri
CEO | Chief Executive Officer | - | 12/04/2023 |
| Director of Finance/CFO | - | 01/12/2015 | |
| Investor Relations Contact | - | 01/10/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 30/10/1996 | |
Juan Alonso
BRD | Director/Board Member | - | 06/07/2010 |
| Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.66% | +2.47% | -25.73% | +10.77% | 855M | |
| +1.86% | +0.48% | +55.50% | +163.08% | 1,082B | |
| +3.57% | +3.29% | +68.60% | +61.03% | 633B | |
| +3.99% | +3.05% | +37.93% | +93.37% | 461B | |
| +3.86% | +1.64% | +31.35% | +24.29% | 338B | |
| -0.56% | +0.96% | +39.86% | +36.64% | 299B | |
| -0.08% | +1.30% | +30.37% | +44.02% | 291B | |
| -1.54% | +2.81% | -27.56% | -39.45% | 222B | |
| +3.55% | +4.41% | +25.45% | +66.28% | 202B | |
| +4.21% | +2.65% | +17.47% | +71.11% | 163B | |
| Average | +1.95% | +4.40% | +25.32% | +53.11% | 369.33B | |
| Weighted average by Cap. | +2.24% | +5.53% | +41.76% | +82.99% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 18.32B 1.05B 916M 842M 785M 1.49B 99.82B 1.51B 10.11B 3.93B 49.07B 3.94B 3.85B 169B | 19.24B 1.1B 962M 884M 824M 1.56B 105B 1.59B 10.62B 4.13B 51.52B 4.13B 4.04B 178B |
| Net income | 2.14B 122M 107M 98.21M 91.55M 174M 11.64B 176M 1.18B 458M 5.72B 459M 449M 19.72B | 2.25B 129M 113M 103M 96.44M 183M 12.26B 186M 1.24B 483M 6.03B 483M 473M 20.77B |
| Net Debt | 3.86B 221M 193M 178M 165M 314M 21.04B 319M 2.13B 828M 10.34B 829M 812M 35.64B | 3.46B 198M 173M 159M 148M 282M 18.87B 286M 1.91B 743M 9.28B 744M 728M 31.96B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/07/26 | MXN 15.33 | +0.66% | 493,025 |
| 02/07/26 | MXN 15.23 | -2.37% | 3,487,891 |
| 01/07/26 | MXN 15.60 | +3.79% | 3,977,498 |
| 30/06/26 | MXN 15.03 | +0.80% | 6,164,745 |
| 29/06/26 | MXN 14.91 | -0.33% | 2,412,960 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- LAB B Stock
Select your edition
All financial news and data tailored to specific country editions
